Edition:
India

Doxa Q3 net loss at SEK 2.3 million

Oct 20 (Reuters) - Doxa Ab ::Q3 net sales sek ‍3.4​ million versus sek 4.0 million year ago.Q3 net loss sek ‍2.3​ million versus loss sek 2.9 million year ago.

12:00pm IST

PledPharma Q3 net loss widens to SEK ‍​27.3 million

Oct 20 (Reuters) - PLEDPHARMA AB (PUBL) ::Q3 NET LOSS SEK ‍​27.3 MILLION VERSUS LOSS SEK 7.9 MILLION YEAR AGO.

11:30am IST

ThromboGenics cash and investments up at 113.4 million euros

Oct 20 (Reuters) - THROMBOGENICS NV ::CASH AND INVESTMENTS €113.4 MILLION AS OF END OF SEPT. 2017 VERSUS €65.1 MILLION AT END OF JUNE 2017‍​.ANNOUNCES NOVARTIS WILL INVEST €10 MILLION IN THROMBOGENICS CAPITAL.

11:00am IST

BB Biotech Q3 net profit down at CHF 365 million

Oct 20 (Reuters) - BB BIOTECH AG ::PRODUCT APPROVALS AND SOLID COMPANY RESULTS LEAD THE BIOTECH SECTOR HIGHER.Q3 ‍NET PROFIT AMOUNTED TO CHF 365 MN VERSUS PROFIT OF CHF 392 MN REPORTED IN Q3 LAST YEAR​.

10:30am IST

Markets

  • Sectors
  • Asia
  • U.S.
  • Europe

Sector Summary

Upcoming Events

No related earnings announcements are currently scheduled within the next 7 days.